Search results for "Image-Guided Biopsy"

showing 10 items of 18 documents

German Survey on EUS-Guided Diagnosis and Management of Gastrointestinal Stromal Tumors (GISTs) - Evidence or "Gut-Feeling"?

2015

To examine practice patterns of endosonographers in diagnosing and managing gastrointestinal stromal tumors (GISTs) in Germany.A modified published survey (Ha et al., Gastrointest Endosc 2009) was sent to endosonographic ultrasound (EUS) customers in Germany. The survey was also publicized on the homepage of an EUS interest group. To avoid duplicate opinions, participants were asked to return one survey per institution.142 centers of roughly 850 German EUS centers responded. 25 % were from University hospitals and 74 % from community hospitals. 61 % performed 2 EUS scans for suspected subepithelial lesions/week. Although 97 % of respondents believed that tissue acquisition with CD117 immuno…

Endoscopic ultrasoundImage-Guided Biopsymedicine.medical_specialtyGastrointestinal Stromal Tumorsmedia_common.quotation_subjectBiopsy Fine-NeedleSensitivity and SpecificityEndosonographySurveys and QuestionnairesBiopsyMedicineHumansRadiology Nuclear Medicine and imagingGastrointestinal stromal tumors (GISTs)Practice Patterns Physicians'neoplasmsUltrasonography Interventionalmedia_commonGastrointestinal Neoplasmsmedicine.diagnostic_testGiSTbiologybusiness.industryCD117Stomachmedicine.diseasedigestive system diseasesEndoscopyFine-needle aspirationFeelingbiology.proteinRadiologybusinessUltraschall in der Medizin (Stuttgart, Germany : 1980)
researchProduct

A Magnetic Resonance Imaging–Based Prediction Model for Prostate Biopsy Risk Stratification

2018

IMPORTANCE: Multiparametric magnetic resonance imaging (MRI) in conjunction with MRI–transrectal ultrasound (TRUS) fusion-guided biopsies have improved the detection of prostate cancer. It is unclear whether MRI itself adds additional value to multivariable prediction models based on clinical parameters. OBJECTIVE: To determine whether an MRI-based prediction model can reduce unnecessary biopsies in patients with suspected prostate cancer. DESIGN, SETTING, AND PARTICIPANTS: Patients underwent MRI, MRI-TRUS fusion-guided biopsy, and 12-core systematic biopsy in 1 session. The development cohort used to derive the prediction model consisted of 400 patients from 1 institution enrolled between …

Image-Guided BiopsyMaleCancer Researchmedicine.medical_specialtyProstate biopsy030232 urology & nephrologyRisk Assessment03 medical and health sciencesProstate cancer0302 clinical medicineProstateBiopsymedicineHumansAgedUltrasonographyOriginal Investigationmedicine.diagnostic_testReceiver operating characteristicbusiness.industryProstateProstatic NeoplasmsMagnetic resonance imagingMiddle AgedPrognosismedicine.diseaseCombined Modality TherapyMagnetic Resonance ImagingTreatment Outcomemedicine.anatomical_structureOncology030220 oncology & carcinogenesisCohortRadiologybusinessImage-Guided BiopsyBiomarkers
researchProduct

Acetic acid compared with i-scan imaging for detecting Barrett's esophagus: a randomized, comparative trial.

2013

Background Traditional surveillance in patients with Barrett's esophagus (BE) has relied on random biopsies. Targeted biopsies that use advanced imaging modalities may significantly improve detection of specialized columnar epithelium (SCE). Objective We compared the efficacy of targeted biopsies that used i -scan or acetic acid to random biopsies in the detection of SCE. Design Patients with visible columnar lined epithelium or known BE were randomized at a 1:1 ratio to undergo acetic acid application or i -scan with targeted biopsies. Setting Targeted biopsies were performed based on surface architecture according to the Guelrud classification followed by 4-quadrant biopsies. Patients A t…

Image-Guided BiopsyMalemedicine.medical_specialtyImaging modalitiesAcetic acidchemistry.chemical_compoundBarrett EsophagusPrimary outcomeEsophagusmedicineHumansRadiology Nuclear Medicine and imagingIn patientEsophagusColoring AgentsAcetic Acidbusiness.industryOptical ImagingGastroenterologyComparative trialMiddle Agedmedicine.diseaseSurgeryStainingmedicine.anatomical_structurechemistryBarrett's esophagusFemaleIndicators and ReagentsEsophagoscopybusinessNuclear medicineGastrointestinal endoscopy
researchProduct

Predicting Gleason Group Progression for Men on Prostate Cancer Active Surveillance: Role of a Negative Confirmatory Magnetic Resonance Imaging-Ultra…

2018

Active surveillance has gained acceptance as an alternative to definitive therapy in many men with prostate cancer. Confirmatory biopsies to assess the appropriateness of active surveillance are routinely performed and negative biopsies are regarded as a favorable prognostic indicator. We sought to determine the prognostic implications of negative multiparametric magnetic resonance imaging-transrectal ultrasound guided fusion biopsy consisting of extended sextant, systematic biopsy plus multiparametric magnetic resonance imaging guided targeted biopsy of suspicious lesions on magnetic resonance imaging.All patients referred with Gleason Grade Group 1 or 2 prostate cancer based on systematic…

Image-Guided BiopsyMalemedicine.medical_specialtyUrologymedicine.medical_treatment030232 urology & nephrology03 medical and health sciencesProstate cancer0302 clinical medicineBiopsyMedicineHumansProspective StudiesProspective cohort studyWatchful WaitingMultiparametric Magnetic Resonance ImagingUltrasonography InterventionalAgedRetrospective Studiesmedicine.diagnostic_testbusiness.industryProstateProstatic NeoplasmsMagnetic resonance imagingRetrospective cohort studyMiddle Agedmedicine.diseasePrognosisMagnetic Resonance ImagingDisease ProgressionRadiologyNeoplasm GradingbusinessImage-Guided BiopsyWatchful waitingThe Journal of urology
researchProduct

Current role of computed tomography-guided transthoracic needle biopsy of metastatic lung lesions.

2015

ABSTRACT  Aim: As part of the Catania symposium on lung metastasectomy we reviewed our practice of computed tomography (CT)-guided percutaneous transthoracic needle biopsy of pulmonary metastatic lesions with particular emphasis on diagnostic accuracy and nature of complications lesions. Materials & methods: 25 patients with metastatic lesions of the lung have been evaluated between May 2010 and February 2014. Inclusion criteria consisted of patients with histologically confirmed, metastatic disease of the lung, those receiving a CT-guided needle biopsy, were at least 18 years of age; and with adequate hepatic, renal and hematological function. We recorded also the size of the sampled …

Image-Guided BiopsyMaleCancer Researchmedicine.medical_specialtyOpen biopsyPercutaneousLung NeoplasmsSettore MED/21 - Chirurgia ToracicaMetastasislung metastasimedicineHumansTransthoracic needle biopsyLungAgedAged 80 and overLungbusiness.industryCT-guided biopsyBiopsy NeedleGeneral MedicineMiddle Agedmedicine.diseasemedicine.anatomical_structureOncologyPneumothoraxCT-guided biopsy; lung metastasis; transthoracic needle biopsyFemaleRadiologytransthoracic needle biopsyMetastasectomyComplicationbusinessSettore MED/36 - Diagnostica Per Immagini E RadioterapiaTomography X-Ray ComputedFuture oncology (London, England)
researchProduct

Prospective Evaluation of PI-RADS™ Version 2 Using the International Society of Urological Pathology Prostate Cancer Grade Group System

2017

The PI-RADS™ (Prostate Imaging Reporting and Data System), version 2 scoring system, introduced in 2015, is based on expert consensus. In the same time frame ISUP (International Society of Urological Pathology) introduced a new pathological scoring system for prostate cancer. Our goal was to prospectively evaluate the cancer detection rates for each PI-RADS, version 2 category and compare them to ISUP group scores in patients undergoing systematic biopsy and magnetic resonance imaging-transrectal ultrasound fusion guided biopsy.A total of 339 treatment naïve patients prospectively underwent multiparametric magnetic resonance imaging evaluated with PI-RADS, version 2 with subsequent systemat…

Image-Guided BiopsyMalemedicine.medical_specialtyPathologyUrology030232 urology & nephrology030218 nuclear medicine & medical imaging03 medical and health sciencesProstate cancer0302 clinical medicinePredictive Value of TestsProstateBiopsymedicineMedical imagingHumansProspective StudiesMultiparametric Magnetic Resonance ImagingAgedUltrasonographymedicine.diagnostic_testbusiness.industryProstatic NeoplasmsMagnetic resonance imagingMiddle Agedmedicine.diseaseMagnetic Resonance ImagingPI-RADSProstate-specific antigenmedicine.anatomical_structureRadiologyNeoplasm GradingbusinessJournal of Urology
researchProduct

Role of apparent diffusion coefficient values in prostate diseases characterization on diffusion-weighted magnetic resonance imaging.

2019

BACKGROUND: To evaluate if normal and pathological prostate tissue can be distinguished by using apparent diffusion coefficient (ADC) values on magnetic resonance imaging (MRI) and to understand if it is possible to differentiate among pathological prostate tissues using ADC values.METHODS:Our population consisted in 81 patients (mean age 65.4 years) in which 84 suspicious areas were identified. Regions of interest were placed over suspicious areas, detected on MRI, and over areas with normal appearance, and ADC values were recorded. Statistical differences between ADC values of suspicious and normal areas were evaluated. Histopathological diagnosis, obtained from targeted biopsy using MRI-…

Image-Guided BiopsyMaleProstatic DiseasesProstate DiseasesUrologymedicine.medical_treatmentPopulation030232 urology & nephrologyurologic and male genital diseases030218 nuclear medicine & medical imagingDiffusion03 medical and health sciencesProstate cancer0302 clinical medicineProstateImage Processing Computer-AssistedmedicineHumansEffective diffusion coefficienteducationAgedRetrospective StudiesAged 80 and overProstate MRI Diffusion Weighted ImagingAtypical small acinar proliferationeducation.field_of_studymedicine.diagnostic_testbusiness.industryProstatectomyProstateProstatic NeoplasmsMagnetic resonance imagingMiddle Agedmedicine.diseasebody regionsDiffusion Magnetic Resonance Imagingmedicine.anatomical_structureNephrologyNeoplasm GradingbusinessNuclear medicineAlgorithms
researchProduct

Technical Feasibility of Electromagnetic US/CT Fusion Imaging and Virtual Navigation in the Guidance of Spine Biopsies.

2020

 To test the technical feasibility of electromagnetic computed tomography (CT) + ultrasound fusion (US)-guided bone biopsy of spinal lesions. This retrospective study included 14 patients referred for biopsy of spinal bone lesions without cortical disruption or intervertebral disc infection. Lesions were located in the sacrum (n = 4), lumbar vertebral body (n = 7) or intervertebral disc (n = 3). Fusion technology matched a pre-procedure CT scan with real-time ultrasound. The first six procedures were performed under both standard CT and CT + US fusion guidance (group 1). In the last eight procedures, the needle was positioned under fusion imaging guidance alone, and CT was only used at the …

Image-Guided BiopsyImage fusionmedicine.diagnostic_testbusiness.industryUltrasoundRetrospective cohort studyIntervertebral discSacrum030218 nuclear medicine & medical imaging03 medical and health sciences0302 clinical medicinemedicine.anatomical_structureBone lesion030220 oncology & carcinogenesisBiopsymedicineProcedure DurationFeasibility StudiesHumansRadiology Nuclear Medicine and imagingNuclear medicinebusinessTomography X-Ray ComputedElectromagnetic PhenomenaRetrospective StudiesUltraschall in der Medizin (Stuttgart, Germany : 1980)
researchProduct

Risk of adverse pathology at prostatectomy in the era of MRI and targeted biopsies; rethinking active surveillance for intermediate risk prostate can…

2021

Abstract Purpose Men with intermediate risk (IR) prostate cancer (CaP) are often excluded from active surveillance (AS) due to higher rates of adverse pathology (AP). We determined our rate of AP in men who underwent multiparametric MRI (MpMRI) with combined biopsy (CB) consisting of targeted biopsy (TB) and systematic biopsy (SB) prior to radical prostatectomy (RP). Methods A retrospective review was conducted of men with Gleason Grade Group (GG) 2 disease who underwent RP after SB alone or after preoperative MRI with CB. AP was defined as either pathologic stage T3a (AP ≥ T3a) or pathologic stage T3b (AP ≥ T3b) and/or GG upgrading. Rates of AP were determined for both groups and those who…

Image-Guided BiopsyMalePathologymedicine.medical_specialtyUrologymedicine.medical_treatment030232 urology & nephrologyDiseaseGleason gradeLogistic regression03 medical and health sciencesProstate cancer0302 clinical medicineBiopsymedicineHumansRetrospective StudiesProstatectomymedicine.diagnostic_testbusiness.industryProstatectomyProstateProstatic NeoplasmsCancerMiddle Agedmedicine.diseaseMagnetic Resonance ImagingOncology030220 oncology & carcinogenesisbusinessIntermediate riskUrologic Oncology: Seminars and Original Investigations
researchProduct

Negative biopsy of focal hepatic lesions: Decision tree model for patient management

2019

OBJECTIVE. The purpose of this study was to investigate patient- and procedure-related variables affecting the false-negative rate of ultrasound (US)-guided liver biopsy and to develop a standardized patient-tailored predictive model for the management of negative biopsy results. MATERIALS AND METHODS. We retrospectively included 389 patients (mean age ± SD, 62 ± 12 years old) who had undergone US-guided liver biopsy of 405 liver lesions between January 1, 2013, and June 30, 2015. We collected multiple patient- and procedure-related variables. By comparing pathology reports of biopsy and the reference standard (further histology or imaging follow-up), we were able to categorize the biopsy r…

AdultImage-Guided BiopsyMalemedicine.medical_specialtyRadiology Nuclear Medicine and ImagingFalse Negative Result030218 nuclear medicine & medical imaging03 medical and health sciencesCore biopsyFalse-negative result0302 clinical medicineBiopsymedicineHumansFalse Negative ReactionsUltrasonography InterventionalAgedRetrospective StudiesAged 80 and overFine-needle aspirationmedicine.diagnostic_testUS-guided liver biopsybusiness.industryLiver DiseasesDecision TreesUltrasoundnutritional and metabolic diseasesGeneral MedicineMiddle AgedPatient managementDiagnostic errorFine-needle aspiration030220 oncology & carcinogenesisLiver biopsyFemaleRadiologybusinessCore biopsyDecision tree model
researchProduct